Codettabio
1 known investors
Codetta Bio develops the Concerto System, a biomarker detection platform that combines digital PCR, qPCR, and immunoPCR technology to simultaneously measure proteins, DNA, and RNA from a single sample for multi-omics applications.
BiotechDeep TechMedical Devices